Lungs News and Research

RSS

Janssen working with The Union to evaluate SIRTURO (bedaquiline) in patients with MDR-TB

Janssen Research & Development, LLC today announced a collaboration with the International Union Against Tuberculosis and Lung Disease (The Union) to include SIRTURO (bedaquiline) in the STREAM Study.

6 Nov 2014

AZD3965 drug inhibits growth of tumours in the lab

Manchester scientists have shown that a new drug inhibits the growth of tumours in the lab and that its effectiveness is improved by combining it with radiotherapy - suggesting a new approach that could be used in the clinic.

6 Nov 2014

OGT workshop to focus on using latest genomic technologies for accelerating cancer research

Oxford Gene Technology, The Molecular Genetics Company, will present a workshop titled ‘An Integrated Genomic Approach to Tumor Profiling’ at the Association for Molecular Pathology annual meeting on the 12-15th November at National Harbor, MD.

From Oxford Gene Technology 6 Nov 2014

Patients who receive lung cancer diagnosis during emergency visit report difficulties in seeing GP

MANY patients whose lung cancer is diagnosed as an emergency in hospital reported difficulties in previously seeing their GP, according to research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool today (Tuesday).

6 Nov 2014

M2Gen, Moffitt to serve as Central Laboratory and Biorepository for The National MDS Study

Moffitt Cancer Center and M2Gen have been awarded a contract from the National Institutes of Health's National Heart, Lung, and Blood Institute (NHLBI) to serve as the Central Laboratory and Biorepository for The National Myelodysplastic Syndromes Natural History Study (The National MDS Study).

6 Nov 2014

Asthma patients using behavioral therapy can improve lung health over the long-term

Asthma patients taught to habitually resist the urge to take deep breaths when experiencing symptoms were rewarded with fewer symptoms and healthier lung function, according to a new study from Southern Methodist University, Dallas.

6 Nov 2014

LA BioMed to receive Phase II funding through Grand Challenges Explorations

Los Angeles Biomedical Research Institute announced today that it will receive Phase II funding through Grand Challenges Explorations, an initiative created by the Bill & Melinda Gates Foundation that enables individuals worldwide to test bold ideas to address persistent health and development challenges.

6 Nov 2014

Bluebeards Original joins with Lung Cancer Alliance to raise awareness about lung cancer

Bluebeards Original is pleased to announce that it has joined with the Lung Cancer Alliance in the month of November to help raise awareness about lung cancer and lung cancer screening. Throughout the month of November, Bluebeards Original will donate 5% of every purchase made on bluebeardsoriginal.com, while promoting lung cancer awareness on its site and through social media.

5 Nov 2014

Clinical study data of Advaxis' Lm-LLO immunotherapies to be presented at SITC Annual Meeting

Advaxis, Inc., a cancer immunotherapy company, today announced the abstracts of three preclinical and clinical studies highlighting the survival outcomes and anti-tumor effects of its proprietary Lm-LLO cancer immunotherapy technology at the Society for Immunotherapy of Cancer (SITC) 29th Annual Meeting, November 6-9, 2014 at the Gaylord National Hotel and Convention Center in National Harbor, Maryland.

5 Nov 2014

UCLA study: Asthma harms more than just the lungs, may be more harmful than previously thought

Asthma may be more harmful than was previously thought, according to UCLA researchers who found that genetic damage is present in circulating, or peripheral, blood. Doctors previously thought that the genetic damage it caused was limited to the lungs.

5 Nov 2014

BYU study: Exposure to cigarette smoke can cause weight gain

New research is challenging the decades-old belief that smoking cigarettes helps keep you slim.

5 Nov 2014

Type 2 diabetes and cardiovascular disease share common risk factors

Type 2 diabetes (T2D) and cardiovascular disease (CVD) appear to have a lot in common. They share risk factors such as obesity and they often occur together. If they also share the same genetic underpinings, then doctors could devise a way to treat them together too.

4 Nov 2014

Gefitinib drug boosts oesophageal cancer patients' survival by up to six months

Patients with a specific type of oesophageal cancer survived longer when they were given the latest lung cancer drug, according to trial results being presented at the National Cancer Research Institute (NCRI) Cancer Conference today (Wednesday).

4 Nov 2014

People with lactose intolerance at lower risk of suffering from certain cancers

People with lactose intolerance are at lower risk of suffering from lung, breast and ovarian cancers, according to a new study by researchers at Lund University and Region Skåne in Sweden.

4 Nov 2014

Researchers make significant advancement in early diagnosis of invasive cancers

A team of researchers from Inserm led by Paul Hofman (Inserm Unit 1081/University of Nice) has just made a significant advance in the area of early diagnosis of invasive cancers. In a study which has just been published in the journal PLOS ONE, the team shows that it is possible to detect, in patients at risk of developing lung cancer, early signs, in the form of circulating cancer cells, several months, and in some cases several years, before the cancer becomes detectable by CT scanning.

4 Nov 2014

Health impacts of inhalable constituents of thirdhand smoke

Ever walked into a hotel room and smelled old cigarette smoke? While the last smoker may have left the room hours or even days ago, the lingering odors—resulting from noxious residue that clings to walls, carpets, furniture, or dust particles—are thanks to thirdhand smoke.

4 Nov 2014

Astellas, Dana-Farber to develop K-Ras inhibitors for treatment of lung, pancreatic cancers

Dana-Farber Cancer Institute (Dana-Farber) and Astellas Pharma Inc. today announced a three-year collaboration to research and develop small molecule inhibitors of oncogenic K-Ras for the treatment of cancer, including lung cancer.

4 Nov 2014

Seno Imagio breast imaging system and associated predictive model can help eliminate breast biopsies

Seno Medical Instruments, Inc., the company pioneering the development of opto-acoustic technology as a new tool to improve the process of diagnosing breast cancer, announced that the use of the Seno Imagio breast imaging system and the associated predictive model appear to have the potential to significantly improve the physicians’ ability to accurately rule out breast cancer compared to traditional ultrasound alone.

4 Nov 2014

CytRx provides overview of clinical development programs, reports 2014 Q3 financial results

CytRx Corporation (CYTR), a biopharmaceutical research and development company specializing in oncology, today reported financial results for the three months ended September 30, 2014, and also provided an overview of recent accomplishments by and upcoming milestones for its clinical development programs.

4 Nov 2014

New policy targeting hospital readmissions for COPD may hurt vulnerable patients, say experts

Last week, the federal government revealed that it will fine more than 2,600 hospitals in the coming year, because too many Medicare patients treated at these hospitals are ending up back in the hospital within 30 days of going home. Two new conditions have been added in this round of penalties: elective hip and knee replacement and chronic lung disease.

3 Nov 2014

Lungs News and Research

Janssen working with The Union to evaluate SIRTURO (bedaquiline) in patients with MDR-TB

AZD3965 drug inhibits growth of tumours in the lab

OGT workshop to focus on using latest genomic technologies for accelerating cancer research

Patients who receive lung cancer diagnosis during emergency visit report difficulties in seeing GP

M2Gen, Moffitt to serve as Central Laboratory and Biorepository for The National MDS Study

Asthma patients using behavioral therapy can improve lung health over the long-term

LA BioMed to receive Phase II funding through Grand Challenges Explorations

Bluebeards Original joins with Lung Cancer Alliance to raise awareness about lung cancer

Clinical study data of Advaxis' Lm-LLO immunotherapies to be presented at SITC Annual Meeting

UCLA study: Asthma harms more than just the lungs, may be more harmful than previously thought

BYU study: Exposure to cigarette smoke can cause weight gain

Type 2 diabetes and cardiovascular disease share common risk factors

Gefitinib drug boosts oesophageal cancer patients' survival by up to six months

People with lactose intolerance at lower risk of suffering from certain cancers

Researchers make significant advancement in early diagnosis of invasive cancers

Health impacts of inhalable constituents of thirdhand smoke

Astellas, Dana-Farber to develop K-Ras inhibitors for treatment of lung, pancreatic cancers

Seno Imagio breast imaging system and associated predictive model can help eliminate breast biopsies

CytRx provides overview of clinical development programs, reports 2014 Q3 financial results

New policy targeting hospital readmissions for COPD may hurt vulnerable patients, say experts

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News